Biliary Tract Disease: Duct Stones and Acute Cholangitis

0:00Welcome to Board Pearls. This is episode three of four of the Biliary Tract Disease chapter, in the Pancreatic and Biliary Disease module. This episode is the stone in the bile duct: the probability framework that decides who goes straight to ERCP, and acute cholangitis, where the same stone turns septic and the timing of decompression becomes the whole management.

0:22Start with stones in the duct, because the whole problem sits on a probability question. ERCP is a useful procedure with an unfriendly complication profile, headlined by post-ERCP pancreatitis, which is common overall and climbs much higher in young women with a normal bilirubin and suspected sphincter pathology, and that risk is why the framework is tiered: you earn the right to do an ERCP by raising the pretest probability of a stone high enough that the procedural risk is justified. The framework divides patients into three tiers, high probability above fifty percent, intermediate at ten to fifty, and low under ten, and the tier dictates the test. High probability requires any one of three features: a stone seen in the duct on imaging, clinical ascending cholangitis, or a bilirubin over four with a common bile duct dilated above six millimeters in a patient who still has a gallbladder, and any one of those sends the patient straight to ERCP because the probability of a retrievable stone justifies the risk. Intermediate probability is everything else that looks suspicious, meaning any abnormal liver chemistry without a high-tier feature, a dilated duct without a visualized stone, or age over fifty-five with biliary pain, and these patients should not go straight to ERCP because a meaningful fraction won't have a stone and the procedure becomes an empty risk, so the right move is to confirm or refute the stone first with MRCP or endoscopic ultrasound.

1:44The choice between those two is itself a teaching point: MRCP is non-invasive and images the whole biliary tree without sedation but misses small stones under six millimeters because its resolution can't reliably catch microlithiasis or sludge, while endoscopic ultrasound brings the transducer within centimeters of the distal duct and catches the sludge and tiny stones MRCP misses, so when the question is small-stone or sludge disease, endoscopic ultrasound is better, and when it's an anatomic survey of the duct, MRCP is fine.

2:13Low probability is none of the above, with normal chemistries, normal caliber, and no red flag, and these patients go to laparoscopic cholecystectomy without pre-operative duct imaging, adding intraoperative cholangiography selectively if the anatomy prompts it.

2:30There's a subtlety even inside the high-probability tier, because only a majority of high-risk patients actually have a stone at ERCP, so some endoscopists still run an MRCP or endoscopic ultrasound even on high-risk patients to avoid an empty procedure, accepting a small delay to spare a stone-free patient the pancreatitis risk, and while the evidence doesn't mandate that pre-ERCP imaging, the logic is consistent with the rest of the framework. Take the young woman with two episodes of right-upper-quadrant pain after fatty meals, afebrile, with a bilirubin of one point six, mildly elevated transaminases, an alkaline phosphatase around one sixty-five, and a common bile duct of eight millimeters without a visualized stone: she sits squarely in the intermediate tier, and the temptation is to send her to ERCP because the duct is dilated and the enzymes are abnormal, but that's a mistake because she doesn't meet a high-risk criterion, so the right next step is MRCP, or endoscopic ultrasound if you suspect small stones, and when her labs trend down over a day a stone becomes less likely still and she's spared a procedure she didn't need.

3:23Two more wrinkles before leaving duct stones: first, stones in a post-cholecystectomy patient follow a clean two-year rule, where stones within two years are usually retained from the original gallbladder while stones beyond two years are usually new brown pigment stones formed inside the duct under stasis and bacterial deconjugation, so a patient returning three years out with a duct stone has a shifted etiology and the bile-leak framing is wrong. Second, large stones, anything a centimeter or larger, are hard to extract through a conventional sphincterotomy, because a sphincterotomy can only enlarge the opening to the diameter of the intraduodenal duct and cutting further risks perforation or bleeding, so a centimeter-plus stone hits that mechanical limit, and the first-line therapy is sphincterotomy plus large-balloon dilation, which radially stretches the orifice without cutting further, with cholangioscopy-directed lithotripsy that fragments the stone under direct vision as the alternative.

4:22That moves to cholangitis, where the stone has the same biology but the patient is septic and the time pressure is different. Cholangitis is ascending bacterial infection of an obstructed biliary tree, and the mechanism that matters is hydraulic: stagnant bile colonizes with enteric organisms, then the obstruction raises intraductal pressure above the pressure in the hepatic sinusoids, and bacteria and endotoxin reflux from bile into the bloodstream, which is why cholangitis turns septic so fast, and why antibiotics alone can't fix it, because they suppress bacteremia for a while but the closed obstructed duct keeps reseeding, so the central intervention is decompression.

4:56The Charcot triad of right-upper-quadrant pain, fever, and jaundice is present in only about half to two-thirds of cases, so the absence of the full triad doesn't exclude the diagnosis, and the Reynolds pentad adds altered mental status and hypotension to identify the severely septic patient already failing organs.

5:14The Tokyo grade sets the severity and the timing. Severe disease is defined by any organ dysfunction: cardiovascular changes needing vasopressors, neurologic changes, a respiratory oxygenation ratio under three hundred, a renal creatinine over two, a hepatic INR over one and a half, or a hematologic platelet count under one hundred thousand. Any one of those needs biliary decompression within twenty-four hours.

5:41Moderate disease requires any two of five inflammatory criteria: a white count above twelve thousand or below four thousand, a fever of thirty-nine or higher, age seventy-five or older, a bilirubin over five, or a low albumin, and two of those need ERCP within forty-eight hours. Mild disease has no organ dysfunction and none of the moderate criteria, and gets an elective ERCP within twenty-four to forty-eight hours after stabilizing on antibiotics. And the key evidence is that ERCP within forty-eight hours reduces inpatient mortality and shortens stay compared with delay, and that benefit holds across all three grades, not just the severely ill.

6:22That data point is the answer to a common trap. The elderly woman who arrives with fever, jaundice, a white count above twenty thousand, a bilirubin of three, hypotension that responds to fluids, and a dilated duct looks acutely septic, gets antibiotics and fluids, and six hours later her temperature is down, her pressure is solid, and the pain is better, and the temptation is to declare victory on the antibiotics, get an MRCP in the morning, and schedule the ERCP later in the week. That's the wrong read, because clinical stabilization on antibiotics doesn't equal resolved obstruction, since the duct is still blocked and the antibiotics are only suppressing bacteremia while the closed space behind the ampulla persists, so as the antibiotic levels dip the bacteria climb back, and she still meets high-risk criteria and needs ERCP within forty-eight hours regardless of how comfortable she looks.

7:12Empiric antibiotics target enteric gram-negatives and anaerobes, with a third-generation cephalosporin plus metronidazole, or piperacillin-tazobactam, or a carbapenem in healthcare-associated or immunocompromised or recently instrumented patients, narrowed once cultures return, and when ERCP fails or the anatomy makes it impossible, as in a gastric bypass, endoscopic-ultrasound-guided drainage and percutaneous transhepatic cholangiography are the rescues. Stone-driven cholangitis is the dominant story, but malignancy, anastomotic stricture, and stent occlusion produce the same syndrome through the same mechanism with the same decompression imperative, while sclerosing cholangitis and IgG4-related disease produce recurrent cholangitis from dominant strictures and have their own framework in the cholestatic liver chapter.

8:03So the acquired stone-and-infection side of the bile duct runs on one idea in two registers. The elective register is probability: ERCP is held behind a pretest threshold because the procedure has its own complication profile, so an abnormal liver test alone doesn't earn it, and the intermediate tier goes to MRCP or endoscopic ultrasound first to confirm the stone. The urgent register is cholangitis, where the obstruction itself drives a sepsis cascade that antibiotics can only suppress, so decompression is mandatory and its timing scales with organ stress, within twenty-four hours for organ dysfunction and forty-eight for the rest, with clinical improvement on antibiotics never mistaken for a relieved obstruction.

8:46The next episode takes the structural and iatrogenic bile duct: the congenital choledochal cysts and their cancer-driving anatomy, the post-cholecystectomy bile leak and stricture where the injury level decides whether a stent can work at all, and sphincter of Oddi dysfunction as it's now reclassified.

9:03For the full chapter, the practice vignettes, and the topic-tagged question bank, head to board pearls dot com. You'll find the rest of the series on Apple Podcasts, Spotify, or wherever you listen to podcasts. That brings us to the end of episode three of four of chapter twenty-seven, and I'll see you in the next one.